Landos Biopharma Company
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
.jpeg)
Industry:
End-to-end Drug Development
Headquarters:
Blacksburg, Virginia, United States
Founded Date:
2017-06-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
6
Total Funding:
70000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-08-13
Last Funding Type:
Series B
Register and Claim Ownership